Impact of Intermittent Fasting and Mediterranean Diet on the Physical Health of the Elderly
NCT ID: NCT06480669
Last Updated: 2024-06-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
17 participants
INTERVENTIONAL
2024-01-01
2024-06-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The objective was to determine whether a 12-hour daily intermittent fasting regimen combined with a Mediterranean diet can improve analytical and anthropometric values in the elderly.
A total of 17 individuals of both sexes, over 60 years old, autonomous, and with preserved cognitive capacity participated. They were randomly divided into two groups: 8 people in the intervention group performed intermittent fasting along with a Mediterranean diet, and 9 in the control group adopted only a Mediterranean diet. The intervention lasted 3 months, with measurements taken at the beginning and end of the intervention.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Time Restricted Feeding (TRF)
8 participants who followed a 12/12 Time Restricted Feeding (12 consecutive hours of fasting, from 20:30 to approximately 8:30 the following day).
Time Restricted Feeding
8 participants who practiced a 12/12 TRF (12 hours of fasting, from approximately 20:30 to 8:30 the following day).
Mediterranean diet
A control group consisting of 9 participants who followed a standard Mediterranean diet.
Mediterranean Diet
A control group consisting of 9 participants who followed a standard Mediterranean diet.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Time Restricted Feeding
8 participants who practiced a 12/12 TRF (12 hours of fasting, from approximately 20:30 to 8:30 the following day).
Mediterranean Diet
A control group consisting of 9 participants who followed a standard Mediterranean diet.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Belong to the Bombarda health centre.
* Preserved cognitive capacity.
* Autonomy for basic and instrumental activities of daily living.
* Ability to follow a TRF and/or adopt a Mediterranean dietary pattern.
Exclusion Criteria
* Serious or chronic uncontrolled disease.
* Specific treatment that could alter blood and/or anthropometric values.
* Poorly controlled type 1 or type 2 insulin-dependent diabetes mellitus.
* Present or past episode of eating disorder (ED).
* High alcohol consumption.
61 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad de Zaragoza
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
María Isabel Iguacel Azorín
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Zaragoza
Zaragoza, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI23/610
Identifier Type: -
Identifier Source: org_study_id